Literature DB >> 16324161

Outcome of a multidisciplinary approach to pediatric migraine at 1, 2, and 5 years.

Marielle A Kabbouche1, Scott W Powers, Anna-Liisa B Vockell, Susan L LeCates, Priscilla L Ellinor, Ann Segers, Paula Manning, Danny Burdine, Andrew D Hershey.   

Abstract

OBJECTIVE: To assess the long-term effectiveness and outcome of multidisciplinary treatment of childhood headaches 1, 2, and 5 years after initial treatment.
BACKGROUND: Headaches are a common problem for children and adolescents and for many patients continue into adulthood. Outcome research for pediatric migraine headaches is limited, thus restricting knowledge of the effectiveness of long-term management and outcome.
METHODS: Headache characteristics were assessed at the initial visit and were reevaluated 1, 2, and 5 years later in independent sub-groups of consecutive patients. These characteristics included headache frequency, severity, average duration, school absences, and overall perceived response to treatment.
RESULTS: At 1 year, 96 patients were evaluated (mean age = 11.0 +/- 3.4, 59% females), 69 patients at 2 years (mean age = 10.6 +/- 3.4, 48% females), and 32 at 5 years (mean age = 10.5 +/- 3.9, 66% females). The headaches were reported as better in 94% at 1 year, 85% at 2 years, and 94% at 5 years. The initial frequency was at 13.4 +/- 10.8 headaches per month, 4.9 +/- 7.0 at 1 year (P < .001), 4.7 +/- 7.6 at 2 years (P < .001), and 4.5 +/- 7.5 at 5 years (P < .001). The severity decreased from 6.8 +/- 1.8 to 5.1 +/- 2.3 at 1 year (P < .001), to 5.0 +/- 2.4 at 2 years (P < .001), and to 4.6 +/- 2.5 at 5 years (P < .01). The school days missed per month showed a marked decrease from 4.5 +/- 9.5 at initial visit to 1.55 +/- 2.8 at 5 years (P < .001). Patients that were only seen at their initial visit and did not choose to return for follow-up had less frequent and shorter duration headaches on initial visit when compared with the rest of the sample and continued to be doing well at the 1-, 2-, and 5-year assessments.
CONCLUSIONS: Multidisciplinary treatment was found to be effective for children and adolescents with improvement of multiple outcome variants of pediatric migraine care, including frequency, severity, and school days missed. Patients who did not return to follow-up evaluation were more likely to have less frequent and shorter duration headaches at initial presentation. Regular follow-up care is needed for those children with more severe initial headache presentation.

Entities:  

Mesh:

Year:  2005        PMID: 16324161     DOI: 10.1111/j.1526-4610.2005.00261.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  14 in total

Review 1.  Pediatric post-traumatic headache.

Authors:  Maria-Carmen B Wilson; Stanley J Krolczyk
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 2.  Treatment adherence in patients with headache: a systematic review.

Authors:  Rachelle R Ramsey; Jamie L Ryan; Andrew D Hershey; Scott W Powers; Brandon S Aylward; Kevin A Hommel
Journal:  Headache       Date:  2014-04-17       Impact factor: 5.887

3.  Predictors of Short-Term Prognosis While in Pediatric Headache Care: An Observational Study.

Authors:  Serena L Orr; Abigail Turner; Marielle A Kabbouche; Paul S Horn; Hope L O'Brien; Joanne Kacperski; Susan LeCates; Shannon White; Jessica Weberding; Mimi N Miller; Scott W Powers; Andrew D Hershey
Journal:  Headache       Date:  2019-01-23       Impact factor: 5.887

4.  Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Authors:  Christina L Szperka; Juliana VanderPluym; Serena L Orr; Christopher B Oakley; William Qubty; Irene Patniyot; Ana Marissa Lagman-Bartolome; Cynthia Morris; Jessica Gautreaux; M Cristina Victorio; Suzanne Hagler; Sona Narula; Meghan S Candee; Catalina Cleves-Bayon; Rashmi Rao; Robert H Fryer; Alma R Bicknese; Marcy Yonker; Andrew D Hershey; Scott W Powers; Peter J Goadsby; Amy A Gelfand
Journal:  Headache       Date:  2018-10-15       Impact factor: 5.887

5.  Experience of Botulinum Toxin A Injections for Chronic Migraine Headaches in a Pediatric Chronic Pain Clinic.

Authors:  Lisgelia Santana; Cherry Liu
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

Review 6.  Management of pediatric migraine: Current concepts and controversies.

Authors:  Ryan M Hung; Daune L MacGregor
Journal:  Indian J Pediatr       Date:  2009-01-07       Impact factor: 1.967

Review 7.  Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification.

Authors:  James A Charles; B L Peterlin; Alan M Rapoport; Steven L Linder; Marielle A Kabbouche; Fred D Sheftell
Journal:  J Headache Pain       Date:  2009-06-09       Impact factor: 7.277

Review 8.  Overview of diagnosis and management of paediatric headache. Part I: diagnosis.

Authors:  Aynur Ozge; Cristiano Termine; Fabio Antonaci; Sophia Natriashvili; Vincenzo Guidetti; Ciçek Wöber-Bingöl
Journal:  J Headache Pain       Date:  2011-02-27       Impact factor: 7.277

9.  Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study.

Authors:  Thomas-Martin Wallasch; Peter Kropp
Journal:  J Headache Pain       Date:  2012-07-12       Impact factor: 7.277

Review 10.  Pediatric Headache Clinic Model: Implementation of Integrative Therapies in Practice.

Authors:  Anna Esparham; Anne Herbert; Emily Pierzchalski; Catherine Tran; Jennifer Dilts; Madeline Boorigie; Tammie Wingert; Mark Connelly; Jennifer Bickel
Journal:  Children (Basel)       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.